Autoimmune retinopathy: A review and summary

Seminars in Immunopathology

Volumn 30, Issue 2, 2008, Pages 127-134

  Heckenlively, John R ^a   Ferreyra, Henry A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Autoimmune disease; Autoimmune retinopathy; AZOOR; Cancer associated retinopathy; Cystoid macular edema; Melanoma associated retinopathy

Indexed keywords

ALPHA TOCOPHEROL; ANTIBODY; ASCORBIC ACID; BETA CAROTENE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE ACETATE; RETINA ANTIBODY; TRIAMCINOLONE; UNCLASSIFIED DRUG; XANTHOPHYLL;

ACUTE ZONAL OCCULT OUTER RETINOPATHY; AUTOIMMUNE DISEASE; CLINICAL FEATURE; ELECTRORETINOGRAM; EYE INJURY; HUMAN; IMMUNOBLOTTING; LOW DRUG DOSE; MULTIPLE EVANESCENT WHITE DOT SYNDROME; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA DEGENERATION; RETINITIS PIGMENTOSA; RETINOPATHY; REVIEW;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINAL DISEASES;

EID: 42449091430     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-008-0114-7     Document Type: Review

References (27)

1. Chan JW (2003) Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 48:12-38
2. Hooks JJ, Tso MOM, Detrick B (2001) Retinopathies associated with antiretinal antibodies. Clin Diagn Lab Immunol 8:853-858
3. Koh AH, Hogg CR, Holder GE (2001) The incidence of negative ERG in clinical practice. Doc Ophthalmol 102(1):19-30
4. Heckenlively J, Fawzi AA, Oversier J, Jordan BL, Aptsiauri N (2000) Autoimmune retinopathy; patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthal 118:1525-1533
5. Cross S, Salomao DR, Parisi JE, Kryzer TJ, Bradley EA, Mines JA, Lam BL, Lennon VA (2003) Paraneo-plastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 54:38-50
6. Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606-613
7. Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4:5 Jun 4
8. Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR (1993) Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34(1):91-100
9. Thirkill CE, FitzGerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL (1989) Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve, and cancer cells. N Engl J Med 321:1589-1594
10. Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL (1992) The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci 33:2768-2772
11. Polans AS, Burton MD, Haley TL, Crabb JW, Palczewski K (1993) Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest Ophthalmol Vis Sci 34:81-90
12. Jankowska R, Witkowska D, Porȩbska I, Kuropatwa M, Kurowska E, Gorczyca WA (2004) Serum antibodies to retinal antigens in lung cancer and sarcoidosis. Pathobiology 71:323-328
13. Shiraga S, Adamus G (2002) Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 132:72-82
14. Adamus G, Amundson D, Seigel GM, Machnicki M (1998) Anti-enolase-a autoantibodies in cancer-associated retinopathhy: epitope mapping and cytotosicity on retinal cells. J Autoimmun 11:671-677
15. Heckenlively JR, Aptsiauri N, Nusinowitz S, Peng C, Hargrave P (1996) Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations. Trans Am Ophthalmol Soc XCIV:179-206
16. Heckenlively J, Jordan B, Aptsiauri N (1999) An association of antiretinal antibodies and cystoid macular edema in retinitis pigmentosa patients. Am J Ophthalmol 127:565-578
17. Ohguro H, Ogawa KI, Maeda T, Maeda A, Maruyama I (1999) Cancer-associated retinopathy induced by both anti-recoverin and Anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 40:3160-3167
18. Potter MJ, Adamus G, Szabo SM, Lee R, Moshaseb K, Behn D (2002) Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 134:128-130
19. Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MO (1992) "On" response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 33:477-483
20. Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262-266
21. Gittinger JW Jr, Smith TW (1999) Cutaneous melanoma-associated paraneoplastic retinopathy: histopathologic observations. Am J Ophthalmol 127:612-614
22. Jacobson DM, Adamus G (2001) Retinal anti-biolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol 131:806-808
23. Pfohler C, Haus A, Palmowski A, Ugurel S, Ruprecht KW, Thirkill CE, Tilgen W, Reinhold U (2003) Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma. Br J Dermatol 149:74-78
24. Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases
25. Kellner U, Bornfeld N, Foerster MH (1995) Severe course of cutaneous melanoma associated paraneoplastic retinopathy. Br J Ophthalmol 79:746-752
26. Kiratli H, Thirkill CE, Bilgic S, Eldem B, Kececi A (1997) Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site. Eye 11:889-892
27. Chan C, O'Day J (2001) Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Experiment Ophthalmol 29(4):235-238 (Aug)